Mirum Pharmaceuticals, Inc. MIRM FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s FX effect on cash?
- Mirum Pharmaceuticals, Inc. (MIRM) reported FX effect on cash of -$1.27M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s FX effect on cash changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s FX effect on cash decreased by 220.6% year-over-year, from $1.06M to -$1.27M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.